FIELD: medicine, ultrasound diagnostics.
SUBSTANCE: invention can be used to search for sentinel lymph nodes in breast cancer. To do this, an ultrasound examination of the affected mammary gland, tumour structure, and regional lymph flow zones is performed. Then, using an insulin syringe with a 26G needle, fractional injections of Sonovue contrast agent are made intradermally into the upper outer quadrant of the mammary gland at 3 points of 0.2 ml each. Then, within 30–60 seconds after injection, a superficial massage of the injection site is performed in the direction from the areola of the mammary gland to the axillary region. Then an ultrasound scan of the area of interest is performed in Contrast mode and a video loop is recorded on an ultrasound machine. The passage of the contrast agent through the lymphatic ducts and the filling of the axillary lymph nodes with contrast are assessed. If within 5–7 minutes the lymph node has accumulated contrast, its boundaries are detailed, and chyle vascularization has occurred; provided that contrasted tubular structures of the lymphatic ducts and formations in the axillary region are visualized in Contrast mode, the search result is assessed as positive.
EFFECT: reliable visualization and analysis of the state of the lymphatic ducts and axillary lymph nodes of the first order in the projection of regional zones of lymphatic drainage at the preoperative stage, in the absence of radiation exposure.
1 cl, 5 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETECTION OF SIGNAL LYMPHATIC NODES IN BREAST CANCER PATIENTS BY COLLOIDAL RADIOPHARMACEUTICALS WITH VARIOUS PARTICLE DIAMETRES | 2011 |
|
RU2469334C1 |
METHOD OF DIAGNOSING REGRESSION OF BREAST CANCER AFTER NEOADJUVANT DRUG THERAPY | 2022 |
|
RU2806299C1 |
METHOD FOR OPTIMIZING LYMPH NODE DISSECTION IN PRIMARY RESECTABLE BREAST CANCER | 2017 |
|
RU2691568C1 |
METHOD OF PERFORMING ORGAN-CONSERVING SURGERY BY VACUUM-ASSISTED BIOPSY OF BREAST TUMOR BED AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH HER2-DEPENDENT OR TRIPLE-NEGATIVE BREAST CANCER SUBTYPE | 2023 |
|
RU2810795C1 |
METHOD OF DIAGNOSING DAMAGE TO AXILLARY LYMPH NODES IN BREAST TUMORS | 2023 |
|
RU2808919C1 |
METHOD FOR ASSESSING HISTOLOGICAL MATERIAL OBTAINED USING VACUUM-ASSISTED BIOPSY FOR REMOVAL OF TUMOUR BED IN PATIENTS DIAGNOSED WITH BREAST CANCER HER2-POSITIVE OR THRICE-NEGATIVE SUBTYPE AFTER NEOADJUVANT SYSTEMIC THERAPY | 2023 |
|
RU2824957C1 |
METHOD FOR "SENTINEL" LYMPH NODE BIOPSY WHEN PERFORMING MASTECTOMY IN BREAST CANCER PATIENTS WITH STAGE TISN0M0 OR T1N0M0 OR T2N0M0 OR T3N0M0 AND TUMOR LOCATION IN UPPER-INTERNAL BREAST QUADRANT | 2022 |
|
RU2794812C2 |
METHOD OF BIOPSY OF THE SENTINEL LYMPH NODE DURING RESECTION OF THE MAMMARY GLAND IN CASE OF STAGE TISN0M0, OR T1N0M0, OR T2N0M0, OR T3N0M0 AND TUMOR LOCALIZATION IN THE UPPER OUTER QUADRANT OF THE MAMMARY GLAND | 2022 |
|
RU2796779C2 |
METHOD OF SURGICAL TREATMENT OF BREAST CANCER AT EARLY STAGES OF TUMOR PROCESS | 2018 |
|
RU2698932C1 |
METHOD OF SIGNAL LYMPH NODE BIOPSY IN PATIENTS WITH BREAST CANCER | 2014 |
|
RU2549488C1 |
Authors
Dates
2024-02-06—Published
2022-08-14—Filed